11. Biotech NetWorkshop

28. – 29. June 2017, Munich

Learn more

PRI-002

Priavoid has successfully applied to start a Phase I clinical trial with PRI-002, a drug for the causal treatment of Alzheimer’s disease. A Phase II clinical trial is in preparation and is scheduled to start in 2018.

News & Events:

Priavoid closes financing round

Priavoid closes financing round

12. Februar 2021
Sprunginnovationsprojekt geht neue Wege in der Alzheimer-Therapie

Sprunginnovationsprojekt geht neue Wege in der Alzheimer-Therapie

11. Februar 2021
Alzheimer´s Research: Important Milestone for PRI-002

Alzheimer´s Research: Important Milestone for PRI-002

4. Februar 2021
Nobel Prize winner Stanley Prusiner joins Priavoid’s supervisory board

Nobel Prize winner Stanley Prusiner joins Priavoid’s supervisory board

9. Dezember 2020
New CEO of Priavoid

New CEO of Priavoid

2. September 2020
Priavoid Headquarters at LSC Düsseldorf

Priavoid Headquarters at LSC Düsseldorf

6. März 2020
09th BIO.NRW Business Angel Congress

09th BIO.NRW Business Angel Congress

3. März 2020
BIO-EUROPE SPRING 2020

BIO-EUROPE SPRING 2020

3. März 2020
BIO.NRW MEDICA-FORUM

BIO.NRW MEDICA-FORUM

3. Dezember 2019
DGN Kongress 2019

DGN Kongress 2019

2. Oktober 2019
AAIC 2019

AAIC 2019

5. Juli 2019
Keystone Symposium

Keystone Symposium

3. Juni 2019
Neuro4D Conference

Neuro4D Conference

6. Mai 2019
Seed Investment

Seed Investment

6. Mai 2019
AD/PD 2019 – Lisbon

AD/PD 2019 – Lisbon

26. März 2019
AsiaTIDES 2019

AsiaTIDES 2019

5. Februar 2019
MINC Symposium

MINC Symposium

23. Oktober 2018
BioRiver Boost! 2018

BioRiver Boost! 2018

23. Oktober 2018
Biomembranes 2018

Biomembranes 2018

5. Oktober 2018
The Nobel Prize

The Nobel Prize

5. Oktober 2018
Boulder Peptide Symposium

Boulder Peptide Symposium

5. September 2018
BioPharm America 2018

BioPharm America 2018

5. September 2018
19th International Conference

19th International Conference

5. September 2018
AAIC 2018 – Chicago

AAIC 2018 – Chicago

5. Juni 2018
BIO International Convention

BIO International Convention

2. Mai 2018
Bio Varia 2018

Bio Varia 2018

2. Mai 2018
Deutsche Biotechnologietage

Deutsche Biotechnologietage

27. März 2018
Undoing Aging – Berlin

Undoing Aging – Berlin

8. März 2018
BIO-Europe Spring 2018

BIO-Europe Spring 2018

27. Februar 2018
07th BIO.NRW Business Angel Congress

07th BIO.NRW Business Angel Congress

15. Februar 2018
3rd German Pharm-Tox Summit – Göttingen

3rd German Pharm-Tox Summit – Göttingen

26. Januar 2018
11th Annual European Life Sciences CEO Forum & Exhibition

11th Annual European Life Sciences CEO Forum & Exhibition

26. Januar 2018
Biotech NetWorkshop – Kreuth

Biotech NetWorkshop – Kreuth

23. Januar 2018
12th Annual Drug Discovery for Neurodegeneration Conference

12th Annual Drug Discovery for Neurodegeneration Conference

23. Januar 2018
Prof. Willbold´s interview with PharmaVentures

Prof. Willbold´s interview with PharmaVentures

23. Januar 2018
ISO 9001:2015 certification

ISO 9001:2015 certification

7. Dezember 2017
Biotech and Money – London

Biotech and Money – London

1. Dezember 2017
Science4Life – Frankfurt

Science4Life – Frankfurt

1. Dezember 2017
Caesar / DZNE Bonn

Caesar / DZNE Bonn

22. November 2017
Düsseldorf-Jülich Symposium on Neurodegenerative Diseases

Düsseldorf-Jülich Symposium on Neurodegenerative Diseases

16. November 2017
BioEurope Berlin

BioEurope Berlin

20. Oktober 2017
Science September 7th, 2017

Science September 7th, 2017

10. September 2017
2nd International Conference in Pharmacology

2nd International Conference in Pharmacology

10. September 2017
AAIC London

AAIC London

24. Juli 2017
Neuroscience 2017

Neuroscience 2017

16. Juli 2017
11. Biotech NetWorkshop

11. Biotech NetWorkshop

31. Mai 2017
BIO International Convention

BIO International Convention

31. Mai 2017
Clinical trial with PRI-002

Clinical trial with PRI-002

31. Mai 2017